Solid Biosciences Inc (NAS:SLDB)
$ 3.68 -0.35 (-8.68%) Market Cap: 147.03 Mil Enterprise Value: 635,000.00 PE Ratio: 0 PB Ratio: 0.86 GF Score: 31/100

Q3 2020 Solid Biosciences Inc Earnings Call Transcript

Nov 05, 2020 / 01:30PM GMT
Release Date Price: $48.6
Operator

Ladies and gentlemen, thank you for standing by and welcome to the Solid Biosciences update call. (Operator Instructions) Please be advised that today's conference may be recorded. Later, we will conduct a question-and-answer session and instructions will be given at that time. (Operator Instructions)

I would now like to hand the conference over to your speaker today, Ms. Jennifer Ziolkowski, Chief Financial Officer. Ma'am, you may begin.

Jennifer Ziolkowski
Solid Biosciences Inc. - CFO & Treasurer

Thank you, Crystal. Good morning, and welcome to the Solid Biosciences Third Quarter 2020 Financial Results and Business Update Conference Call. Today's call is being recorded.

Before we get started, I would like to remind everyone that during this conference call, we may make forward-looking statements, including statements about the company's financial results, financial guidance, future business strategies and operations and product development and regulatory process, including statements about the ongoing IGNITE DMD clinical trial. Actual

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot